COLA MICHAEL F
Insider CIK 1188940 · MDGN President and CEO, Director · VNDA Director · PATH Director · CERC Chief Executive Officer, Director · SAGE Director · PHAT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals, I | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 63,920 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 21,500 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 21,500 | — | $0 | 21,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 39,798 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-06-10 | 2024-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 29,298 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 18,798 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 9,947 | — | $0 | 9,947 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2022-05-25 | 2022-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2021-10-01 | 2021-10-04 | 78,116 | — | $0 | 78,116 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-07-01 | 2021-07-02 | 51,740 | — | $0 | 51,740 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2021-05-21 | 2021-05-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-04-01 | 2021-04-05 | 70,881 | — | $0 | 70,881 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 850,000 | — | $0 | 850,000 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 64,798 | — | $0 | 64,798 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-10-01 | 2020-10-02 | 76,674 | — | $0 | 76,674 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-07-01 | 2020-07-06 | 64,683 | — | $0 | 64,683 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 84,322 | — | $0 | 84,322 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CERC Aevi Genomic Medicine, LLC | P Buy | 2020-06-09 | 2020-06-11 | 100,000 | $2.50 | $250.0K | 175,746 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-06-09 | 2020-06-11 | 100,000 | $2.50 | $250.0K | 175,746 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2020-05-21 | 2020-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 1,500,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 50,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 661,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 450,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 21,181 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 250,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 292,087 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 17,327 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 250,000 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-02-03 | 2020-02-05 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer | 2020-02-03 | 2020-02-05 | 2,267,859 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | A Award | 2020-02-03 | 2020-02-05 | 75,746 | — | $0 | 75,746 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy | 2019-12-05 | 2019-12-09 | 2,049,376 | $0.13 | $266.4K | 2,267,859 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | P Buy | 2019-10-29 | 2022-02-18 | 9,798 | $19.00 | $186.2K | 9,798 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2019-06-13 | 2019-06-17 | 5,000 | — | $0 | 15,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2019-06-05 | 2019-06-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2018-06-14 | 2018-06-18 | 661,000 | — | $0 | 661,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 10,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2018-06-06 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2018-05-14 | 2018-05-16 | 450,000 | — | $0 | 450,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy deriv | 2017-10-17 | 2017-10-18 | 21,181 | — | $0 | 21,181 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy | 2017-10-17 | 2017-10-18 | 119,047 | $1.26 | $150.0K | 218,483 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2017-08-11 | 2018-05-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2017-08-11 | 2017-08-15 | 500,000 | — | $0 | 500,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2017-06-15 | 2017-06-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2017-06-07 | 2017-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2017-02-17 | 2017-02-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 13,922 | $28.35 | $394.7K | 13,922 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2016-06-16 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2016-04-15 | 2016-04-19 | 250,000 | — | $0 | 250,000 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2015-10-06 | 2015-10-08 | 38,460 | $6.50 | $250.0K | 99,436 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2015-05-28 | 2015-05-29 | 13,922 | $73.13 | $1.02M | 13,922 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2015-02-18 | 2015-02-20 | 292,087 | — | $0 | 292,087 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2014-12-01 | 2014-12-02 | 60,976 | $4.10 | $250.0K | 60,976 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2014-09-11 | 2014-09-12 | 20,883 | — | $0 | 20,883 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2014-05-22 | 2014-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2014-04-16 | 2014-04-18 | 17,327 | $5.37 | $93.0K | 17,327 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 3,883 | $3.35 | $13.0K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 13,500 | $3.81 | $51.4K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 5,513 | $3.74 | $20.6K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 8,631 | $4.39 | $37.9K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,368 | $3.53 | $22.5K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,238 | $5.36 | $33.4K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,238 | $5.36 | $33.4K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 1,871 | $5.36 | $10.0K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 17,467 | $4.88 | $85.2K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 1,247 | $4.88 | $6.1K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 4,906 | $3.42 | $16.8K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 4,695 | $3.24 | $15.2K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,014 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 7,486 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 4,098 | $2.77 | $11.4K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 2,143 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,750 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 4,714 | $3.10 | $14.6K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,750 | $3.43 | $23.2K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 9,431 | $4.96 | $46.8K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 8,574 | $4.78 | $41.0K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 2,297 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer | 2014-02-21 | 2014-02-25 | 13,500 | $6.80 | $91.8K | 0 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-12-31 | 2014-01-03 | 6,368 | — | $0 | 6,368 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-09-30 | 2013-10-02 | 8,631 | — | $0 | 8,631 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2013-09-13 | 2013-09-17 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-06-30 | 2013-07-02 | 5,513 | — | $0 | 5,513 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2013-06-20 | 2013-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-06-05 | 2013-06-07 | 13,500 | — | $0 | 13,500 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-04-24 | 2013-04-29 | 13,500 | — | $0 | 13,500 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-03-31 | 2013-04-02 | 3,883 | $2.90 | $11.3K | 3,883 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-12-31 | 2013-01-03 | 4,906 | $2.29 | $11.2K | 4,906 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-09-30 | 2012-10-01 | 4,695 | $2.40 | $11.3K | 4,695 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-06-30 | 2012-07-03 | 4,098 | $2.74 | $11.2K | 4,098 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2012-06-14 | 2012-06-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-06-07 | 2012-06-11 | 6,750 | — | $0 | 6,750 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-03-31 | 2012-04-03 | 4,714 | $2.39 | $11.3K | 4,714 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2011-12-31 | 2012-01-04 | 9,431 | $1.19 | $11.2K | 9,431 | SEC↗ |